← Contracts
PT
1364/2025 - Convite à apresentação de proposta por ajuste direto para aquisição de, R1100 - RISPERIDONA [75 MG/0.383 ML; PÓ SUSP INJ LP; SERINGA], R1101 - RISPERIDONA [100 MG/0.490 ML; PÓ SUSP INJ LP; SERINGA]
ID 11242365
· Portal BASE
Price
Base Price
€1,597,844
.00
Effective Price
€4,042
.00
-99.7%
Contract Details
- Contract Type
- Aquisição de bens móveis
- Procedure
- Ajuste Direto Regime Geral
- CPV Code
- 33600000
- Location
- Portugal, Braganca
- Bidder Count
- 1
Winner
LAB. FARMACEUTICOS ROVI, SA.
NIF 980166705
Competition
1 bidder recorded
LAB. FARMACEUTICOS ROVI, SA.
NIF 980166705
Dates
- Publication
- 21 Feb 2025
- Celebration
- 20 Feb 2025
Contracting Entity
Unidade Local de Saúde do Nordeste, E. P. E.
NIF 509932584
Public body
Data Source
Portal BASE
Api
· synced 2026-04-17
Risk Flags
Score 80 · HIGH RISK
A1 · Repeat Direct Award
A1_REPEAT_DIRECT_AWARD
- Authority
- 449
- Supplier
- 253
- Number of Awards
- 4
- Rule
- A1 repeat direct award: 4 awards within 36 months
Detected 2026-03-06
A6 · Low Competition
A6_LOW_COMPETITION
- Rule
- a6_single_bidder
- Bidder count
- 1
Detected 2026-04-17
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
- Base price
- 1597844.0
- Total effective price
- 4042.0
- Ratio
- 0.0025
- Direction
- reduction
- Rule
- A9 price reduction: ratio 0.0025 outside [0.5, 1.5]
Detected 2026-03-06